These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15974143)

  • 1. Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison.
    Small W; Kain S; Laliberte N; Schechter MT; O'Shaughnessy MV; Spittal PM
    Subst Use Misuse; 2005; 40(6):831-43. PubMed ID: 15974143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
    Chakrapani V; Kamei R; Kipgen H; Kh JK
    Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of HIV infection in provincial prisons in British Columbia.
    Rothon DA; Mathias RG; Schechter MT
    CMAJ; 1994 Sep; 151(6):781-7. PubMed ID: 8087754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring motivations to stop injecting in English prisons: qualitative research with former male prisoners.
    Tompkins CN
    Int J Prison Health; 2013; 9(2):68-81. PubMed ID: 25758439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injecting drug use, sexual risk, HIV knowledge and harm reduction uptake in a large prison in Bali, Indonesia.
    Sawitri AA; Hartawan AA; Craine N; Sari AK; Septarini NW; Wirawan DN
    Int J Prison Health; 2016; 12(1):27-38. PubMed ID: 26933990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug use and risk of bloodborne infections: a survey of female prisoners in British Columbia.
    Martin RE; Gold F; Murphy W; Remple V; Berkowitz J; Money D
    Can J Public Health; 2005; 96(2):97-101. PubMed ID: 15850026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
    Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
    PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "It Goes on Everywhere": Injection Drug Use in Canadian Federal Prisons.
    van der Meulen E
    Subst Use Misuse; 2017 Jun; 52(7):884-891. PubMed ID: 28426354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural change amongst drug injectors in Scottish prisons.
    Shewan D; Gemmell M; Davies JB
    Soc Sci Med; 1994 Dec; 39(11):1585-6. PubMed ID: 7817222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The place of syringe exchange programs in reducing harm in Canadian prisoners].
    Orsi MM; Brochu S
    Can J Public Health; 2009; 100(1):29-31. PubMed ID: 19263972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug injection and HIV prevalence in inmates of Glenochil prison.
    Gore SM; Bird AG; Burns SM; Goldberg DJ; Ross AJ; Macgregor J
    BMJ; 1995 Feb; 310(6975):293-6. PubMed ID: 7866170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and knowledge of sexual transmitted infections, drug abuse, and AIDS among male inmates in a Taiwan prison.
    Feng MC; Feng JY; Chen YH; Chang PY; Lu PL
    Kaohsiung J Med Sci; 2012 Dec; 28(12):660-6. PubMed ID: 23217358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.
    Bird AG; Gore SM; Hutchinson SJ; Lewis SC; Cameron S; Burns S
    BMJ; 1997 Jul; 315(7099):21-4. PubMed ID: 9233321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported injection practices among people who use drugs in French prisons: Public health implications (ANRS-Coquelicot survey 2011-2013).
    Michel L; Trouiller P; Chollet A; Molinier M; Duchesne L; Jauffret-Roustide M;
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S268-S276. PubMed ID: 29105203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clean switch: the case for prison needle and syringe programs.
    Chu S
    HIV AIDS Policy Law Rev; 2009 Dec; 14(2):5-19. PubMed ID: 20225504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.
    Kerr T; Stoltz JA; Tyndall M; Li K; Zhang R; Montaner J; Wood E
    BMJ; 2006 Jan; 332(7535):220-2. PubMed ID: 16439401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prison Economy of Needles and Syringes: What Opportunities Exist for Blood Borne Virus Risk Reduction When Prices Are so High?
    Treloar C; McCredie L; Lloyd AR
    PLoS One; 2016; 11(9):e0162399. PubMed ID: 27611849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The politics of harm reduction in federal prisons.
    Watson TM
    Int J Drug Policy; 2014 Sep; 25(5):916-23. PubMed ID: 25018152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior opiate injection and incarceration history predict injection drug use among inmates.
    Calzavara LM; Burchell AN; Schlossberg J; Myers T; Escobar M; Wallace E; Major C; Strike C; Millson M
    Addiction; 2003 Sep; 98(9):1257-65. PubMed ID: 12930213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.